Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2006; 12(32): 5135-5139
Published online Aug 28, 2006. doi: 10.3748/wjg.v12.i32.5135
Increased expression of angiogenin in gastric carcinoma in correlation with tumor angiogenesis and proliferation
Yu Chen, Sheng Zhang, Yu-Peng Chen, Jian-Yin Lin
Yu Chen, Department of Physiology and Pathophysiology, Fujian Medical University, Fuzhou 350004, Fujian Province, China
Sheng Zhang, Yu-Peng Chen, Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, Fujian Province, China
Jian-Yin Lin, Department of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou 350004, Fujian Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Natural Science Foundation of Fujian Province, No.C0110013, and Science and Technology KeyProgram Foundation of Fujian Province, No. 2002Y003
Correspondence to: Professor Jian-Yin Lin, Department of Biochemistry and Molecular Biology, Fujian Medical University, 88 Jiaotong Road, Fuzhou 350004, Fujian Province, China. jylin@mail.fjmu.edu.cn
Telephone: +86-591-83348087 Fax: +86-591-83569132
Received: April 13, 2006
Revised: May 18, 2006
Accepted: May 25, 2006
Published online: August 28, 2006

Abstract

AIM: To investigate the implication of angiogenin (ANG) in the neovascularizaton and growth of human gastric carcinoma (HGC).

METHODS: ANG mRNA expression in HGC specimens obtained by surgical resection from patients with HGC were examined by RT-PCR. ANG, Ki-67, VEGF protein expression and microvessel density (MVD) in HGC specimens were detected by immunohistochemistry.

RESULTS: RT-PCR showed significantly higher ANG mRNA expression (0.482 ± 0.094) in HGC tissues than in the surrounding nontumorous tissues (0.276 ± 0.019, P = 0.03). MVD within tumorous tissues increased significantly with ANG mRNA expression (r = 0.380, P = 0.001) and ANG protein expression (P < 0.01). The ANG expression levels of cancer tissues were positively correlated with VEGF (P < 0.01) and the proliferation index of cancer cells (P < 0.01).

CONCLUSION: ANG is one of the neovascularization factors of HGC. ANG may work in coordination with VEGF, and promote the proliferation of HGC cells.

Key Words: Angiogenin, Gastric carcinoma, Vascular endothelial growth factor, Angiogenesis



INTRODUCTION

Primary gastric carcinoma is one of the most common malignant tumors in China. The mortality rate is as high as 25.53/100 000, accounting for 23.93% of all the deaths caused by malignant tumors[1]. Invasion and metastasis are the main cause for the death of cancer patients. On the other hand, invasion and metastasis of malignant tumors are closely related with angiogenesis of tumor tissue. Angiogenin (ANG) was originally isolated from serum-free supernatants of a cultured human colon adenocarcinoma cell line (HT-29) by Fett etcetera in 1985[2]. ANG possesses a ribonuclease activity[3]. Data have shown that in human colorectal cancer[4], pancreatic cancer[5], and other tumors, the expression of ANG is upregulated. However, the function of ANG in tumor angiogenesis is still unknown[6]. We used RT-PCR and immunohistochemistry to detect the expression of ANG, CD34 and vascular endothelial growth factor (VEGF) in 68 primary gastric carcinomas and the surrounding nontumorous tissues, analyzed their correlation with each other, and explored the functional role of ANG in angiogenesis and growth of gastric carcinoma.

MATERIALS AND METHODS
Materials

The study enrolled 68 human gastric carcinoma (HGC) patients (56 men and 12 women; Ages, mean ± SD, 60 ± 11 years) who underwent gastric surgical resection at The First Affiliated Hospital of Fujian Medical University between March and July of 2002. The specimens for RT-PCR included both cancer tissues and the surrounding nontumorous tissues. The specimens for immunohistochemistry were taken simultaneously. All specimens were 40 g/L formaldehyde-fixed, paraffin-embedded and sliced into 4 μm sections consecutively. None of these patients had preoperative radiative therapy or chemotherapy. All the diagnoses were confirmed by pathology reported by two pathologists. Clinical data of all the patients were reviewed. Histology type, lymph node metastasis stage and TNM stage of each case were determined according to WHO tumor classification standards (stomach cancer)[7]. Twenty-seven patients had well-moderately differentiated adenocarcinoma, and 41 patients had poorly-undifferentiated adenocarcinoma. Fourteen patients were node-negative; 46 had first station lymph node metastasis, and 8 had second or distant lymph node metastasis. Twelve tumors were TNM I, 25 tumors were TNM II, 20 tumors were TNM III, and 11 tumors were TNM IV.

Methods

RNA extraction: Specimens were taken within 30 min after resection, and were stored at -80°C. RNA was extracted from HGC tissue and corresponding nontumorous gastric tissue using Trizol extraction reagent kit (Gibco BRL, USA), according to the instructions of the manual. Concentration and purity of RNA were determined by spectrophotometric method. Integrity of RNA was determined by electrophoresis.

RT-PCR and analysis of the products: ANG primers were synthesized by the Bioasia Biotechnology Company using the method as described previously[10]. Each tube contained 5 × buffer 5 μL, 10 mmol/L dNTP 0.5 μL, DTT 1.25 μL, primers (sense, antisense) 4 μL, RNA template 1 μg, mix-enzyme 0.5 μL, DEPC solution, with a total volume of 25 μL (Titan One Tube RT-PCR system, Roche, Germany). RT-PCR reaction condition is as follows: at 58°C for reverse transcription for 30 min, 94°C incubation for 2 min to terminate reverse transcription, followed by 30 cycles at 94°C for 30 s, at 52°C for 30 s, and at 72°C for 60 s; With a final extension at 72°C for 7 min. RT-PCRs were run in a Bio-rad thermocycler. The results were analysed in a Bio-rad GelDoc-1000 system, relative to the levels of β actin as the control.

Immunohistochemistry: ANG multiclonal antibody 1:25 was purchased from American Santa Cruz Co. VEGF-C multiclonal antibody (ready to use) was provided by American Zymed Co. Monoclonal antibody of CD34 (QBEnd/10, ready to use) and monoclonal antibody of Ki-67 (MIB-1, 1:50) were supplied by American NeoMarkers Co. All operations were done according to the instructions of the manufacturers. Positive specimens were used as positive controls and PBS in substitution of the first antibody was used as a negative control at the same time.

ANG protein expression[8]: Cytoplasm of gastric carcinoma cells was stained brown. According to the staining intensity of the tumor cells, the staining was graded as (-), when staining was weaker than negative control; (+), for light staining; (++), for moderate staining; and (+++), for strong staining.

MVD of HGC tissues[9]: Gastric carcinoma vascular endothelial cells were stained brown. The isolated brown and yellow blood vessel endothelial cells or cell clusters in gastric carcinoma tissues were regarded as a single microvessel (Figure 1A). Areas with the highest microvessel densities were selected under 10 × microscopic magnification. Then the numbers of microvessels stained by CD34 antibody in 10 vision fields were counted under 400 × magnification (0.916 mm2 per visual field), respectively. The average of 3 highest values was taken as MVD. Indistinguishable or indistinct cells were excluded.

Figure 1
Figure 1 Expression of CD34, Ki-67, ANG and VEGF in gastric carcinoma tissue. A: CD34 (S-P × 200); B: Ki-67 (S-P × 400); C: ANG (EnVision × 400); D: VEGF (S-P × 200).

VEGF protein expression: Membrane and cytoplasm of gastric carcinoma cells were stained rose. The staining intensity of the tumor cells was classified as: light staining (+), moderate staining (++), deep staining (+++).

Proliferation index of tumor cells: The nuclei of the positive cells were stained deep brown (Figure 1B). The number of positive cells among 1000 tumor cells was counted per slide and taken as the tumor cell proliferation index.

Statistical analysis

Statistics software package was used for analysis. t test, analysis of variance, chi-square test and correlation analysis were used. P < 0.05 was taken as significance.

RESULTS
ANG mRNA expression in HGC tissues

ANG mRNA and its inner control β-actin were detected both in gastric carcinoma tissues and in corresponding nontumorous gastric tissues of all 68 cases. The RT-PCR products of ANG and β-actin were seen at 402 bp and 234 bp by gel electrophoresis (Figure 2). The expression of ANG mRNA was higher in 68 gastric carcinoma tissues (0.4822 ± 0.0943) than in corresponding nontumorous gastric tissues (0.2758 ± 0.0187, P < 0.05). Although ANG mRNA expression was higher in poorly differentiated carcinomas, in carcinomas invading visceral peritoneum, carcinomas with lymph node metastasis and TNM stage III-IV than in well-moderately differentiated adenocarcinoma, in carcinomas invading lamina and muscularis propria, carcinomas without lymph node metastasis and TNM stage I-II, no statistical difference was found (Table 1).

Table 1 ANG and ANG mRNA expression and clinicopathological characteristics of gastric carcinoma.
CharacteristicsnANG mRNA(mean ± SE)ANG
++++++++++
Age (yr)
< 60371.727 ± 0.28737198
≥ 60312.634 ± 0.698041611
Site
Cardia252.866 ± 0.610011410
Corpus101.310 ± 0.1661144
Antrum252.366 ± 0.73726134
Others81.704 ± 0.5080341
Differentiation
Well-moderate271.986 ± 0.24712159
Poor412.242 ± 0.570292010
Depth of invasion
Lamina and muscularis propria121.384 ± 0.1482262
Visceral peritoneum562.302 ± 0.429192917
Lymph node metastasis
(-)141.722 ± 0.1861193
(+)542.245 ± 0.4452102616
TNM stage
I121.756 ± 0.2121182
II251.621 ± 0.273231010
III-IV312.708 ± 0.73907177
Figure 2
Figure 2 RT-PCR product electrophoresis. 1: β-actin of gastric carcinoma tissue, 234 bp; 2: ANG of gastric carcinoma tissue, 402 bp; 3: molecular weight marker; 4: β-actin of paired adjacent gastric mucosas, 234 bp; 5: ANG of paired adjacent gastric mucosas, 402 bp.
ANG expression in HGC tissues

Immunohistochemistry staining showed that ANG located at the cytoplasm of gastric carcinoma cells as brown particles (Figure 1C). Over 90% of the gastric carcinoma cells were stained positive. The ANG expression level had no correlation with the age of patients, location, histological type, lymph node metastasis, and clinical stage of the tumor (Table 1).

ANG expression and the MVD of tumor tissues

ANG mRNA expression ratio of HGC tissues and the corresponding nontumorous gastric tissues (T/N) was significantly correlated with the MVD of gastric carcinoma tissue. With the increase of ANG mRNA expression, MVD elevated also. A significant positive correlation was found between them (r = 0.380, P < 0.01 ). Also, with increase of ANG expression of gastric carcinoma tissues, MVD rose as well. The MVD of the ANG strong staining group (308.37 ± 25.57) was significantly higher than that of the negative group (196.00 ± 31.34) (P < 0.01).

Correlation between VEGF and ANG expression in HGC

The ANG expression in gastric carcinoma tissues was positively correlated with the expression of VEGF (Figure 1D) (Pearson correlation coefficient = 0.3490, P < 0.01).

Correlation between tumor proliferation index and ANG expression in HGC

The ANG expression levels of cancer tissues were positively correlated with the proliferation index of cancer cells (P < 0.01). The proliferation index of cancer cells of the group with strong ANG expression (579.58 ± 31.38) was much higher than that of the group with weak ANG expression (341.33 ± 84.01).

DISCUSSION

The up-regulation of expression of angiogenic factors in tumor tissue plays the role of switch-on in neoplastic angiogenesis. Research showed that hypoxia could induce up-regulation of ANG expression in human malignant melanoma, whereas it could induce down-regulation of ANG expression in normal melanocytes[10]. It has been shown that ANG mRNA expression is significantly higher in human colorectal cancer[4], pancreatic cancer[5], malignant melanoma[10], bladder carcinoma[11] and other tumors than in normal tissues. Our results are similar to these. The ANG expression levels of gastric carcinoma tissues were significantly higher than that in the surrounding nontumorous gastric mucosas. Both ANG mRNA and protein expression levels had no significant correlation with the patients’ age, location, histological type, lymph node metastasis, and clinical stage of the tumor[12]. Studies on pancreatic cancer[5], invasive breast carcinoma[13] and invasive cervical cancer[14] have obtained similar results. In malignant melanoma, ANG expression is upregulated around necrotic areas and invasive borders of tumors, while necrotic tissues do not express ANG. This suggests that hypoxia is the reason for the upregulation of ANG in gastric carcinoma tissues.

Tumor angiogenesis is the precondition of tumor development. Tumor MVD is recognized as an important index for judging tumor angiogenesis, which is a multi-step process. Under the effect of angiogenic factors, endothelial cells proliferate and migrate to form new vessels, and new blood vessel networks. This study showed a positive correlation between ANG expression levels and tumor vascularity evaluated by MVD, suggesting ANG contributes to the angiogenesis of HGC. In addition, previous studies have shown ANG contributes to the neovascularization of hepatocellular carcinoma[15], human colorectal cancer, and malignant melanoma[10]. ANG is one of the efficient angiogenic factors, and the only angiogenic factor with RNase activity[16]. There are two kinds of ANG-binding proteins on endothelial cells. One is actin, the other is a 170-kDa ANG-binding protein. Binding of ANG to cell surface actin causes activation of a cell-associated protease system and cell invasion. After the cells are activated, they migrate and invade the basement membrane, resulting in a decrease in the local cell density in the vicinity of the migrating cells, which may trigger the putative 170-kDa receptor gene expression in the remaining cells. These cells become ANG-responsive and divide to fill the space left by the migrating cells. The expression of the receptor gene is turned off when the gap is filled and cells become more dense. It may well be possible that the ANG-induced formation of a new capillary network is largely regulated by such cell density-dependent expression of the ANG receptor gene[3].

ANG is required for cell proliferation induced by various other angiogenic proteins including acidic and basic fibroblast growth factors (aFGF and bFGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF). Angiogenin-stimulated rRNA transcription in endothelial cells may thus serve as a crossroad in the process of angiogenesis induced by various angiogenic factors[17].

We found a positive correlation between ANG protein expression and VEGF expression in HGC tissues, suggesting ANG and VEGF may work in coordination in HGC angiogenesis. Asthmatic children have significantly higher levels of VEGF and angiogenin than healthy control children. A significant positive correlation exists between both angiogenic factors[18]. Moreover, a correlation has been found between VEGF and ANG levels during fetal development and in maternal diabetes[19]. Gonadotropin can not only stimulate the secretion of ANG by granulosa cells, but can also stimulate the secretion of VEGF by ovarian follicles. ANG and VEGF may also work together in the angiogenesis of corpus luteum[20]. Meanwhile, it was also found that hypoxia could induce the expression of VEGF[16]. Hypoxic induced factor-1 (HIF-1) binds VEGF oxygen sensitive enhancer under hypoxic conditions. Through the activation of c-Src, it promotes the transcription and expression of VEGF. Expression of ANG may be up-regulated in response to hypoxia within the tumor. A significant increase in the secretion and mRNA expression of ANG from both term placental explants and trophoblast cultures subjected to hypoxia in vitro was observed[21]. One study showed that ANG expression in invasive carcinomas is significantly positively correlated with HIF-1 alpha and the HIF-1 alpha target gene DEC-1[22]. Hypoxia can also induce upregulated expression of ANG in corpus luteum granulosa cells. This is related to two HIF binding sites on the ANG promoter[20]. Moreover, under hypoxic conditions, the ANG and VEGF secreted by renal proximal tubular epithelial cells may modulate angiogenesis and vascular remodeling in the renal interstitium via an increase in the production of HIF-1[23]. Accordingly, hypoxia in HGC tissues may stimulate ANG and VEGF expression through the HIF-1 pathway. ANG and VEGF may work coordinately in the angiogenesis of HGC.

We found that ANG expression levels were closely correlated with rapid growth and metastasis of malignant tumors. Pancreatic cancers with high serum ANG (sANG) levels had larger volumes than those to low sANG levels[5]. ANG expression in the gastric carcinoma tissues was significantly and positively correlated with the proliferation index of cancer cells. This suggests ANG could promote the growth of tumor cells. Studies have found that ANG can specifically combine with the leukemia cell line TF-1 and dose dependently promotes the growth of the leukemia cells[24]. ANG is constitutively translocated into the nucleus of HeLa cells where it stimulates rRNA transcription, ribosome biogenesis, proliferation and tumorigenesis[25].

In summary, ANG contributes to gastric carcinoma angiogenesis, and promotes the growth of tumor cells. Inhibition or blockage of the expression of ANG does not only reduce tumor angiogenesis, but also inhibits the growth of tumors directly. These have potential implications in tumor treatment.

ACKNOWLEDGMENTS

We thank Drs LY Chen and X Lin for their technical assistance.

Footnotes

S- Editor Pan BR L- Editor Zhu LH E- Editor Ma N

References
1.  Li L, Zhang S, Lu F. [Research on characteristics of mortality spectrum and type composition of malignant tumors in China]. Zhonghua Zhong Liu Za Zhi. 1997;19:323-328.  [PubMed]  [DOI]
2.  Shapiro R, Strydom DJ, Olson KA, Vallee BL. Isolation of angiogenin from normal human plasma. Biochemistry. 1987;26:5141-5146.  [PubMed]  [DOI]
3.  Shestenko OP, Nikonov SD, Mertvetsov NP. [Angiogenin and its role in angiogenesis]. Mol Biol (Mosk). 2001;35:349-371.  [PubMed]  [DOI]
4.  Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res. 2000;6:3545-3551.  [PubMed]  [DOI]
5.  Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res. 1996;56:2703-2706.  [PubMed]  [DOI]
6.  Chen Y. Angiogenin and angiogenesis. Guowai Yixue: Shengli Bingli Kexue Yu Linchuang Fence. 2003;3:314-316.  [PubMed]  [DOI]
7.  Fen C, Car F, Cor P, Gui P, Lam R, Meg F, Mun N, Pow S. M, Rug M, Sas M, Sto M, Wat H. Gastric carcinoma. Pathology and genetics of tumours of the digestive system. 1st ed. Lyon: IARC Press 2000; 38-52.  [PubMed]  [DOI]
8.  Zhang S, Li L, Lin H. [A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer]. Zhonghua Zhongliu Zazhi. 2001;23:399-402.  [PubMed]  [DOI]
9.  Chen LY, Zhang S, Lin JY, Huang PS. [Dual effect of angiopoietin-2 on angiogenesis in gastric cancer]. Zhonghua Zhongliu Zazhi. 2004;26:161-164.  [PubMed]  [DOI]
10.  Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröcker EB, Klein CE. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 1999;59:1578-1583.  [PubMed]  [DOI]
11.  Zhao H, Grossman HB, Delclos GL, Hwang LY, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005;104:30-35.  [PubMed]  [DOI]
12.  Chen Y, Zhang S, Chen YP, Lin JY. [Effect of angiogenin on angiogenesis in gastric carcinoma]. Ai Zheng. 2005;24:317-320.  [PubMed]  [DOI]
13.  Montero S, Guzmán C, Cortés-Funes H, Colomer R. Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res. 1998;4:2161-2168.  [PubMed]  [DOI]
14.  Bodner-Adler B, Hefler L, Bodner K, Leodolter S, Frischmuth K, Kainz C, Mayerhofer K. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN). Anticancer Res. 2001;21:809-812.  [PubMed]  [DOI]
15.  Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, Takahashi M, Yoshizaki N, Takimoto R, Terui T, Niitsu Y. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res. 2003;9:4852-4859.  [PubMed]  [DOI]
16.  Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci USA. 1994;91:12096-12100.  [PubMed]  [DOI]
17.  Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene. 2005;24:445-456.  [PubMed]  [DOI]
18.  Abdel-Rahman AM, el-Sahrigy SA, Bakr SI. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest. 2006;129:266-271.  [PubMed]  [DOI]
19.  Lassus P, Teramo K, Nupponen I, Markkanen H, Cederqvist K, Andersson S. Vascular endothelial growth factor and angiogenin levels during fetal development and in maternal diabetes. Biol Neonate. 2003;84:287-292.  [PubMed]  [DOI]
20.  Koga K, Osuga Y, Tsutsumi O, Momoeda M, Suenaga A, Kugu K, Fujiwara T, Takai Y, Yano T, Taketani Y. Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab. 2000;85:3352-3355.  [PubMed]  [DOI]
21.  Rajashekhar G, Loganath A, Roy AC, Chong SS, Wong YC. Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J Soc Gynecol Investig. 2005;12:310-319.  [PubMed]  [DOI]
22.  Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. J Pathol. 2005;205:585-591.  [PubMed]  [DOI]
23.  Nakamura M, Yamabe H, Osawa H, Nakamura N, Shimada M, Kumasaka R, Murakami R, Fujita T, Osanai T, Okumura K. Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant. 2006;21:1489-1495.  [PubMed]  [DOI]
24.  Zhang YM, Wang L, Ma DL. Growth stimulation effect of human recombinant angiogenin on hematopoietic cells. Zhonghua Xueye Zazhi. 1996;17:195-197.  [PubMed]  [DOI]
25.  Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, Hu GF. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res. 2005;65:1352-1360.  [PubMed]  [DOI]